Concepedia

Bobby Chi-Hung Liaw

BC

5

Publications

166

Citations

5

H-Index

2014

Active since

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of California, San Francisco

Harvard University

Bobby Chi-Hung Liaw is an author at Icahn School of Medicine at Mount Sinai specializing in immunology, immunosuppression, and allergy.

Top concepts

Publications per year

2014–2024

5

Publications

5

Neuroimmunological adverse events associated with immune checkpoint inhibitor: a retrospective, pharmacovigilance study using FAERS database

Takahisa Mikami, Bobby Chi-Hung Liaw, Mizuho Asada et al. · Journal of Neuro-Oncology · 2021 · 97 citations

, , +12

Blood mRNA Expression Profiling Predicts Survival in Patients Treated with Tremelimumab

Yvonne M. Saenger, Jay Magidson, Bobby Chi-Hung Liaw et al. · Clinical Cancer Research · 2014 · 36 citations · Full text

Phase 1 clinical trial of AMG 340, a prostate-specific membrane antigen (PSMA)-targeted T-cell engager with a novel low-affinity CD3 binding domain designed to mitigate toxicity for the treatment of metastatic castration-resistant prostate cancer (mCRPC).

Gerald S. Falchook, Meredith McKean, William K. Kelly et al. · Journal of Clinical Oncology · 2024 · 12 citations

The Impact of Androgen Deprivation Therapy on COVID-19 Illness in Men With Prostate Cancer

Neil J. Shah, Vaibhav G. Patel, Xiaobo Zhong et al. · JNCI Cancer Spectrum · 2022 · 11 citations · Full text

Phase II Trial of Abiraterone Acetate Plus Prednisone in Black Men With Metastatic Prostate Cancer

Che‐Kai Tsao, John P. Sfakianos, Bobby Chi-Hung Liaw et al. · The Oncologist · 2016 · 10 citations · Full text

Rows per page

1–5 of 5